BACKGROUND: Hyponatremia is a common electrolyte imbalance in hospitalized patients. It is associated with significant morbidity and mortality, especially if the underlying cause is incorrectly diagnosed and not treated appropriately. Often, the hospitalist is faced with a clinical dilemma when a patient presents with hyponatremia of an unclear etiology and with uncertain volume status. Syndrome of inappropriate antidiuretic hormone (SIADH) is frequently diagnosed in this clinical setting, but cerebral salt wasting (CSW) is an important diagnosis to consider. OBJECTIVE: We wanted to describe the diagnosis, treatment, and history of CSW to provide clinicians with a better understanding of the differential diagnosis for hyponatremia. CONCLUSION: CSW is a process of extracellular volume depletion due to a tubular defect in sodium transport. Two postulated mechanisms for CSW are the excess secretion of natriuretic peptides and the loss of sympathetic stimulation to the kidney. Making the distinction between CSW and SIADH is important because the treatment for the two conditions is very different.
BACKGROUND: Hyponatremia is a common electrolyte imbalance in hospitalized patients. It is associated with significant morbidity and mortality, especially if the underlying cause is incorrectly diagnosed and not treated appropriately. Often, the hospitalist is faced with a clinical dilemma when a patient presents with hyponatremia of an unclear etiology and with uncertain volume status. Syndrome of inappropriate antidiuretic hormone (SIADH) is frequently diagnosed in this clinical setting, but cerebral salt wasting (CSW) is an important diagnosis to consider. OBJECTIVE: We wanted to describe the diagnosis, treatment, and history of CSW to provide clinicians with a better understanding of the differential diagnosis for hyponatremia. CONCLUSION: CSW is a process of extracellular volume depletion due to a tubular defect in sodium transport. Two postulated mechanisms for CSW are the excess secretion of natriuretic peptides and the loss of sympathetic stimulation to the kidney. Making the distinction between CSW and SIADH is important because the treatment for the two conditions is very different.
Authors: Sheila Singh; Desmond Bohn; Ana P C P Carlotti; Michael Cusimano; James T Rutka; Mitchell L Halperin Journal: Crit Care Med Date: 2002-11 Impact factor: 7.598
Authors: E Berendes; M Walter; P Cullen; T Prien; H Van Aken; J Horsthemke; M Schulte; K von Wild; R Scherer Journal: Lancet Date: 1997-01-25 Impact factor: 79.321
Authors: D Hasan; K W Lindsay; E F Wijdicks; G D Murray; P J Brouwers; W H Bakker; J van Gijn; M Vermeulen Journal: Stroke Date: 1989-09 Impact factor: 7.914
Authors: Mark Sherlock; Eoin O'Sullivan; Amar Agha; Lucy Ann Behan; Danny Rawluk; Paul Brennan; William Tormey; Christopher J Thompson Journal: Clin Endocrinol (Oxf) Date: 2006-03 Impact factor: 3.478
Authors: Jan Leonard; Raymond E Garrett; Kristin Salottolo; Denetta S Slone; Charles W Mains; Matthew M Carrick; David Bar-Or Journal: Scand J Trauma Resusc Emerg Med Date: 2015-11-11 Impact factor: 2.953